Valuation: Edwards Lifesciences Corporation

Market Cap 47.81B 42.03B 39.13B 35.93B 67.48B 4,585B 68.37B 465B 182B 2,264B 179B 176B 7,826B P/E 2026 *
32.3x
P/E 2027 * 25.2x
Enterprise Value 44.19B 38.85B 36.16B 33.21B 62.36B 4,238B 63.18B 430B 168B 2,093B 166B 162B 7,233B EV / Sales 2026 *
6.54x
EV / Sales 2027 * 5.75x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-2.31%
Current month-8.20%
1 month-8.53%
3 months-0.50%
6 months-0.67%
Current year-2.59%
1 week 81.16
Extreme 81.155
89.08
1 month 81.16
Extreme 81.155
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
11/07/26 Tax

Executive/Senior Manager

-109 0.0000%
10/07/26 Fiscal year

Executive/Senior Manager

1,857 0.0003%
09/07/26 Free

Chief Financial Officer

174,045 0.0302%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-2.31%+3.80%+0.45% 47.58B
-1.54%+6.33%+16.98%-0.09% 211B
+2.61%-2.29%-4.37%-23.02% 135B
+5.73%+1.04%-28.04%+10.28% 119B
+2.85%+3.98%-57.12%-13.54% 65.77B
+1.43%+0.59%-25.87%-33.53% 44.44B
-0.49%+5.86%+14.74%+8.87% 39.14B
-0.93%+3.82%+22.53%+30.15% 36.79B
-2.38%+2.59%+73.35%-0.12% 29.37B
+4.00%+2.25%-26.20%-8.32% 28.17B
Average +1.18%+1.32%-1.02%-2.89% 75.63B
Weighted average by Cap. +1.29%+1.58%-2.98%-4.01%

Financials

2026 *2027 *
Net sales 6.76B 5.94B 5.53B 5.08B 9.53B 648B 9.66B 65.72B 25.67B 320B 25.36B 24.82B 1,106B 7.43B 6.53B 6.08B 5.58B 10.48B 712B 10.62B 72.23B 28.21B 352B 27.88B 27.28B 1,215B
Net income 1.46B 1.29B 1.2B 1.1B 2.06B 140B 2.09B 14.23B 5.56B 69.29B 5.49B 5.37B 239B 1.9B 1.67B 1.55B 1.42B 2.68B 182B 2.71B 18.44B 7.2B 89.76B 7.12B 6.96B 310B
Net Debt -3.62B -3.19B -2.97B -2.72B -5.11B -348B -5.18B -35.25B -13.77B -172B -13.6B -13.31B -593B -5.12B -4.5B -4.19B -3.85B -7.22B -491B -7.32B -49.78B -19.44B -242B -19.21B -18.8B -838B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
27/07/26 $83.04 +0.50% 6,707,518
24/07/26 $82.63 -1.42% 10,480,908
23/07/26 $83.82 -0.65% 6,913,372
22/07/26 $84.37 -0.21% 4,512,283
21/07/26 $84.55 -0.53% 5,571,029
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
83.04USD
Average target price
100.60USD
Spread / Average Target
+21.15%

Quarterly revenue - Rate of surprise